Botanical species · safety record

Haplopappus baylahuen

The EFSA Compendium of Botanicals holds 3 constituent measurements for Haplopappus baylahuen. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Haplopappus baylahuen J.Rémy

3Constituent measurements

0Safety records

3Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Coumarins	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Prenyletin	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Rhein	Aerial part of plants	Solvent extraction	—	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Ulloa, Nora Henriquez. Investigation and chromtographic separation of the anthraquinone glucosides in Chilean plants. Anales de la Facultad de Quimica y Farmacia (Universidad de Chile), 1960, p. 113-120.
Schwenker, G., Kloss, P., Engels, W. On the isolation of prenyletin from Haplopappus baylahuen. Pharmazie, 1967, vol. 22, no. 12, p. 724-725.
Vogel, H., Gonzalez, M., Faini, F., Razmilic, L., Rodriguez, J., San Martin, J., Urbina, F. Antioxidant properties and TLC characterization of four Chilean Haplopappus-species known as bailahuen. JOURNAL OF ETHNOPHARMACOLOGY, 2005, vol. 97, no. 1, p. 97-100. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature